| Profiling early humoral response to diagnose novel coronavirus disease (COVID-19) L Guo, L Ren, S Yang, M Xiao, D Chang, F Yang, CS Dela Cruz, Y Wang, ... Clinical infectious diseases 71 (15), 778-785, 2020 | 2106 | 2020 |
| Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China D Chang, M Lin, L Wei, L Xie, G Zhu, CSD Cruz, L Sharma Jama 323 (11), 1092-1093, 2020 | 894 | 2020 |
| Protecting health-care workers from subclinical coronavirus infection D Chang, H Xu, A Rebaza, L Sharma, CSD Cruz The Lancet Respiratory Medicine 8 (3), e13, 2020 | 848 | 2020 |
| Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity AG Solis, P Bielecki, HR Steach, L Sharma, CCD Harman, S Yun, ... Nature 573 (7772), 69-74, 2019 | 412 | 2019 |
| Time kinetics of viral clearance and resolution of symptoms in novel coronavirus infection D Chang, G Mo, X Yuan, Y Tao, X Peng, FS Wang, L Xie, L Sharma, ... American journal of respiratory and critical care medicine 201 (9), 1150-1152, 2020 | 220 | 2020 |
| Chitin and its effects on inflammatory and immune responses D Elieh Ali Komi, L Sharma, CS Dela Cruz Clinical reviews in allergy & immunology 54, 213-223, 2018 | 215 | 2018 |
| Cutting edge: severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome, resulting in dysregulation of eicosanoid immune mediators B Schwarz, L Sharma, L Roberts, X Peng, S Bermejo, I Leighton, ... The Journal of Immunology 206 (2), 329-334, 2021 | 157* | 2021 |
| Innate immunity of the lung: from basic mechanisms to translational medicine D Hartl, R Tirouvanziam, J Laval, CM Greene, D Habiel, L Sharma, ... Journal of innate immunity 10 (5-6), 487-501, 2018 | 137 | 2018 |
| Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19 A Unterman, TS Sumida, N Nouri, X Yan, AY Zhao, V Gasque, JC Schupp, ... Nature communications 13 (1), 440, 2022 | 132 | 2022 |
| A potential role of microvesicle-containing miR-223/142 in lung inflammation D Zhang, H Lee, X Wang, M Groot, L Sharma, CSD Cruz, Y Jin Thorax 74 (9), 865-874, 2019 | 132 | 2019 |
| Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury M Entezari, M Javdan, DJ Antoine, DMP Morrow, RA Sitapara, V Patel, ... Redox biology 2, 314-322, 2014 | 127 | 2014 |
| Inhibition of High-Mobility Group Box 1 Protein (HMGB1) Enhances Bacterial Clearance and Protects against Pseudomonas Aeruginosa Pneumonia in Cystic … M Entezari, DJ Weiss, R Sitapara, L Whittaker, MJ Wargo, JH Li, H Wang, ... Molecular medicine 18, 477-485, 2012 | 120 | 2012 |
| Clinical epidemiology, risk factors, and control strategies of Klebsiella pneumoniae infection D Chang, L Sharma, CS Dela Cruz, D Zhang Frontiers in microbiology 12, 750662, 2021 | 115 | 2021 |
| Atypical pneumonia: updates on Legionella, Chlamydophila, and Mycoplasma pneumonia L Sharma, A Losier, T Tolbert, CSD Cruz, CR Marion Clinics in chest medicine 38 (1), 45-58, 2017 | 106 | 2017 |
| IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses CM Lee, CH He, AM Nour, Y Zhou, B Ma, JW Park, KH Kim, CD Cruz, ... Nature communications 7 (1), 12752, 2016 | 98 | 2016 |
| High mobility group box–1 mediates hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in mice VS Patel, RA Sitapara, A Gore, B Phan, L Sharma, V Sampat, JH Li, ... American journal of respiratory cell and molecular biology 48 (3), 280-287, 2013 | 91 | 2013 |
| The fungal ligand chitin directly binds TLR 2 and triggers inflammation dependent on oligomer size K Fuchs, Y Cardona Gloria, OO Wolz, F Herster, L Sharma, CA Dillen, ... EMBO reports 19 (12), e46065, 2018 | 88 | 2018 |
| JAK-inhibitor and type I interferon ability to produce favorable clinical outcomes in COVID-19 patients: a systematic review and meta-analysis L Walz, AJ Cohen, AP Rebaza, J Vanchieri, MD Slade, CSD Cruz, ... BMC infectious diseases 21 (1), 1-10, 2021 | 84 | 2021 |
| Identification of potent and safe antiviral therapeutic candidates against SARS-CoV-2 X Xiao, C Wang, D Chang, Y Wang, X Dong, T Jiao, Z Zhao, L Ren, ... Frontiers in Immunology 11, 586572, 2020 | 81 | 2020 |
| The kinetics of humoral response and its relationship with the disease severity in COVID-19 L Ren, L Zhang, D Chang, J Wang, Y Hu, H Chen, L Guo, C Wu, C Wang, ... Communications biology 3 (1), 780, 2020 | 71 | 2020 |
